seizures

White arrow on a road pointing to the rising sun
Biotech

Praxis' drug reduces seizures but sees 23% discontinuation rate

Praxis has reported a 56.3% median reduction in seizure frequency, encouraging the biotech to push ahead with plans to start a phase 2/3 study.
Nick Paul Taylor Aug 4, 2025 10:22am
ceribell

Why now was the time for Ceribell’s upsized IPO

Oct 15, 2024 4:00pm
ceribell

Seizure-spotting headset maker Ceribell seeks $101M Nasdaq IPO

Oct 7, 2024 11:30am
brain amyloid alzheimers strings detailed web complicated thought

Praxis epilepsy drug reduces seizures in phase 2 trial

Sep 3, 2024 10:21am
An artists rendition of a seizure in the brain The brain is outlined in neon blue with the overactive neurons in glowing r

Ovid halts preclinical work, IV program after soticlestat fail

Aug 13, 2024 9:15am
free bird maze fly freedom

Stoke's Dravet syndrome med released of partial clinical hold

Aug 7, 2024 8:54am